RxDoctor Payments Data

Guido Torres, MD

Obstetrics & Gynecology · Henderson, NVNPI 1427108604

Payments from drug & device makers

What this record shows

This record is dominated by education: $36,145 of the $39,969 with a category attached, or 90.4%. Intuitive Surgical accounts for 91.5% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2021 at $27,592 and has fallen 99.6% since, to $106 in 2025. Among obstetrics & gynecology clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,969in general payments, 2019–2025

Across 181 payments — averaging $220.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$37K
  • AbbVie$702
  • Pfizer$402
  • Astellas Pharma US Inc$283
  • Caldera Medical, Inc$253
  • Mayne Pharma Commercial LLC$185
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$3,82410%
  • Education$36,14590%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,969 in reported general payments places this provider in the 95th percentile of 308 obstetrics & gynecology providers in Nevada.

See all obstetrics & gynecology providers in Nevada

Medicare billing

Part B allowed, 2024
$11,805
Medicare patients
69
Services billed
125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremproEstrogen,con/M-Progest Acet13$4,780
EstrogelEstradiol15$4,634
YuvafemEstradiol21$2,963
Estradiol89$2,694
Medroxyprogesterone Acetate27$285
Oxybutynin Chloride15$193
Alendronate Sodium12$42

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPrempro$402$4,78013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 308 obstetrics & gynecology providers in Nevada.

Other obstetrics & gynecology in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →